ArticleClinical case reports2025
Essential Thrombocythemia's Role in the Complex Landscape of Vasculitis: A Case Report.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Essential Thrombocythemia's Role in the Complex Landscape of Vasculitis: A Case Report.Clinical case reports · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral gangrenes have been sporadically documented as the initial presentation of essential thrombocythemia (ET), as exemplified in the preceding case reports. Nevertheless, the prevalence of vasculitis-induced skin problems as the primary indication of ET has not been extensively examined. Our case distinguishes itself in this regard, as it proposes a fresh outlook on the etiology of ET. A 52-year-old male presented with worsening pain and bruising in the right toes, following auto-amputation of the left fourth fingertip due to gangrene a month earlier. Examination revealed necrotic wounds on multiple toes. Dorsalis pedis pulses were palpable, and sonography ruled out obstructions. Splenomegaly and thrombocytosis prompted consideration of ET. Marrow analysis confirmed myeloproliferative neoplasia with negative JAK2, CALR, and MPL mutations. Axonal polyneuropathy was evident, and skin biopsy showed leukocytoclastic vasculitis (LCV). The patient was diagnosed with undifferentiated vasculitis, characterized by total signs of ischemia and gangrene of the fingertips, splenomegaly, triple-negative ET, neuropathy (medium vessel involvement), and cutaneous LCV (small vessel involvement). The patient received prednisolone at a dosage of 1 mg/kg and azathioprine concurrently with hydroxyurea, aspirin, cilostazol, and sildenafil. The results indicate a fresh perspective, suggesting that ET may potentially contribute to the development of LCV. The main takeaway lesson from this atypical manifestation highlights the wide range of clinical manifestations associated with ET and encourages further investigation into the complex relationship between thrombocythemia and vasculitis processes. As we delve deeper into these distinct presentations, we gain a more comprehensive understanding of the diverse aspects of ET pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.